Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C

Anatomical Record

Volumn 292, Issue 10, 2009, Pages 1577-1583

  Liu, Huidong ^a   Yang, Yanmei ^a   Xiao, Jianbing ^a   Lv, Yanhong ^a   Liu, Yan ^a   Yang, Huike ^a   Zhao, Linghui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

COX 2; Lymph node metastasis; Lymphatic vessel; VEGF C

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; HUMANS; LUNG NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHENOTYPE; PYRAZOLES; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VESICULAR TRANSPORT PROTEINS;

MUS;

EID: 70449633544     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20940     Document Type: Article

References (40)

1. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. 2003. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97:457-464. (Pubitemid 36133813)
2. Banerji S, Ni J, Wang SX. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801. (Pubitemid 29234556)
3. Bono P, Wasenius VM, Heikkila P. 2004. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10:7144-7149. (Pubitemid 39487698)
4. Boolbol SK, Dannenberg AJ, Chadburn DA, et al. 1996. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56:2556-2560.
5. Caname I, Mitsunobu RK, Akiyoshi K, et al. 2007. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67:10181-10189.
6. Cheng-Chi C, Jin-Yuan S, Yung-Ming J, Jen-Liang S. 2004. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 96:364-375.
7. Costa C, Soares R, Reis-Filho JS, et al. 2004. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Exp Clin Cancer Res 10:6938-6945.
8. Dubois RN, Giardello FM, Smalley WE. 1996. Non-steroidal antiinflammatory drugs, eicosanoids and colorectal cancer prevention. Gastroenterol Clin North Am 25:773-791.
9. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenoma and adenocarcinoma. Gastroentelology 107:1183-1188. (Pubitemid 24294584)
10. George ML, Tutton MG, Janssen F, et al. 2001. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3:420-427. (Pubitemid 32988812)
11. Gunningham SP, Currie MJ, Han C, et al. 2000. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6:4278-4286. (Pubitemid 30840179)
12. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T. 1998. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761-3764. (Pubitemid 28405625)
13. Hu PJ, Yu J, Zeng ZR, et al. 2004. Chemoprevention of gastric cancer by celecoxib in rats. Gut 53:195-200. (Pubitemid 38125505)
14. Joukov V, Pajusola K, Kaipainen A, et al. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298. (Pubitemid 26029207)
15. Kari A, Suresh M, Erkki R. 2004. Lymphangiogenesis and cancer meeting report. Cancer Res 64:9225-9229.
16. Karkkainen MJ, Alitalo K. 2002. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 13:9-18. (Pubitemid 35418310)
17. Makinen T, Veikkola T, Mustjoki S, et al. 2001. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-4773. (Pubitemid 32848629)
18. Mattila MM, Ruohola JK, Karpanen T, et al. 2002. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98:946-951. (Pubitemid 34286696)
19. Oliver G, Detmar M. 2000. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16:773-783. (Pubitemid 34280101)
20. Pepper MS. 2001. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 7:462-468.
21. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. 2000. Chemoprevention of colon cancer by specific cycooxygenase-2 inhibitor, celecoxib, administered during different stage of carcinogenesis. Cancer Res 60:293-297. (Pubitemid 30070754)
22. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. 1997. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280. (Pubitemid 27152551)
23. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro SA. 1991. Hypothesis: non-steroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 83:355-358.
24. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785-3789.
25. Sasai H, Masaki M, Wakitani K. 2000. Suppression of polypogenesis in a new mouse strain with a truncated Apc474 by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21:953-958. (Pubitemid 30265139)
26. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M. 1998. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274:G1061-G1067. (Pubitemid 28304229)
27. Skobe M, Hawighorst T, Jackson DG, et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198. (Pubitemid 32148486)
28. Siironen P, Ristimaki A, Narko K, et al. 2006. VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr Relat Cancer 13:465-473. (Pubitemid 43886669)
29. Soumaoro LT, Uetake H, Takagi Y, et al. 2006. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis. Dis Colon Rectum 49:392-398.
30. Su J, Shih JY, Yen ML, et al. 2004. Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64:554-564. (Pubitemid 38120894)
31. Taketo MM. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90:1529-1536.
32. Thun MJ, Namboodiri MM, Heath CW, Jr. 1991. Aspirin use and reduce risk of fatal colon cancer. N Engl J Med 25:1593-1596.
33. Toyoaki H, Yasushi Y, Hiroyuki A. 1998. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761-3764.
34. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716. (Pubitemid 28257578)
35. Veikkola T, Jussila L, Makinen T, et al. 2001. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223-1231. (Pubitemid 32233963)
36. Williams CS, Dubois RN. 1996. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 270:G393-G400.
37. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, Dubois RN. 1996. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111:1134-1140. (Pubitemid 26327618)
38. Wang WR, Pan ZC, Yan XC. 1987. Isolation of a metastatic associatic subpopulation from a human lung adenocarcinoma cell line in nude mice and studies on its biological properties. Chinese J Oncol 9:412-414.
39. Zhengtang C, Michelle LV, Matthew WB, et al. 2005. Down-regulation of vascular endothelial cell growth factor-c expression using small interfering rna vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65:9004-9011.
40. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. 1999. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198-204. (Pubitemid 29062978)